Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling

Exploring the molecular difference among breast cancer subtypes is of crucial importance in understanding its heterogeneity and seeking its effective clinical treatment. For this, several layers of information including immunohistochemical markers and a variety of high-throughput genomics approaches...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xiaofeng, Chen, Ana, Bai, Zhonghu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206873/
https://www.ncbi.nlm.nih.gov/pubmed/25338681
http://dx.doi.org/10.1038/srep06566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206873/
https://www.ncbi.nlm.nih.gov/pubmed/25338681
http://dx.doi.org/10.1038/srep06566

Ejemplares similares